BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Harmonic Inc
HLIT
$1.49B
| $90K | ﹤0.01% |
13,671
-4,056
| -23% | -$28.1K |
|
|
UCTT
3052
Ultra Clean Holdings
UCTT
$3.98B
| $89.6K | ﹤0.01% |
6,124
-151
| -2% | -$2.1K |
|
3053
QuinStreet
QNST
$1.19B
| $89.5K | ﹤0.01% |
7,112
+1,775
| +33% | +$24.2K |
|
3054
Midland States Bancorp
MSBI
$700M
| $89.4K | ﹤0.01% |
3,432
+1,072
| +45% | +$28.1K |
|
|
GSS
3055
DELISTED
Golden Star Resources Ltd.
GSS
| $89.3K | ﹤0.01% |
31,226
-5,774
| -16% | -$20.1K |
|
3056
Bank of Marin Bancorp
BMRC
$463M
| $89.3K | ﹤0.01% |
2,152
-115
| -5% | -$4.84K |
|
|
VANIW
3057
DELISTED
Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW
| $89.3K | ﹤0.01% |
55,782
| – | – |
|
3058
Axcelis
ACLS
$4.36B
| $89.1K | ﹤0.01% |
5,212
-152
| -3% | -$2.43K |
|
3059
DHT Holdings
DHT
$3.13B
| $88.9K | ﹤0.01% |
14,463
+44
| +0.3% | +$253 |
|
|
CIO
3060
DELISTED
City Office REIT
CIO
| $88.5K | ﹤0.01% |
6,153
+886
| +17% | +$11.6K |
|
3061
Axsome Therapeutics
AXSM
$11.1B
| $88.3K | ﹤0.01% |
4,365
+4,204
| +2,611% | +$108K |
|
3062
Cytokinetics
CYTK
$10B
| $88.3K | ﹤0.01% |
7,757
+2,650
| +52% | +$33.3K |
|
|
FLIC
3063
DELISTED
First of Long Island Corp
FLIC
| $88.1K | ﹤0.01% |
3,871
-195
| -5% | -$4.29K |
|
|
REGI
3064
DELISTED
Renewable Energy Group, Inc.
REGI
| $87.9K | ﹤0.01% |
5,858
+1,736
| +42% | +$24K |
|
3065
POSCO
PKX
$17.9B
| $87.6K | ﹤0.01% |
1,857
-454
| -20% | -$21.3K |
|
3066
Vicor
VICR
$10.8B
| $87.6K | ﹤0.01% |
2,966
+754
| +34% | +$23.3K |
|
3067
Ingles Markets
IMKTA
$1.65B
| $87.4K | ﹤0.01% |
2,249
+655
| +41% | +$23.2K |
|
|
FFIC
3068
DELISTED
Flushing Financial
FFIC
| $87.4K | ﹤0.01% |
4,324
-783
| -15% | -$16K |
|
3069
Tidewater
TDW
$4.69B
| $87.3K | ﹤0.01% |
5,775
-950
| -14% | -$17.9K |
|
3070
LeMaitre Vascular
LMAT
$1.88B
| $87.2K | ﹤0.01% |
2,550
+533
| +26% | +$17K |
|
|
VRS
3071
DELISTED
Verso Corporation
VRS
| $86.6K | ﹤0.01% |
6,997
-3,143
| -31% | -$43K |
|
3072
Peapack-Gladstone Financial
PGC
$830M
| $86.1K | ﹤0.01% |
3,071
+936
| +44% | +$26.3K |
|
3073
Cohu
COHU
$2.8B
| $85.4K | ﹤0.01% |
6,325
-160
| -2% | -$2.22K |
|
3074
ProShares Ultra NASDAQ Biotechnology
BIB
$85.3M
| $84.8K | ﹤0.01% |
1,993
+380
| +24% | +$18K |
|
3075
Nicolet Bankshares
NIC
$3.76B
| $84.7K | ﹤0.01% |
1,273
-41
| -3% | -$2.65K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.